Americas (WHO region) vs Oman: Confirmed cases of MDR-TB started treatment for MDR-TB
Americas (WHO region)
92.0%
in 2012
Oman
100.0%
in 2012
Americas (WHO region) rank
2nd
Oman rank
3rd
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Americas (WHO region)
- Oman
How they compare
Oman currently reports 100.0% against 92.0% in Americas (WHO region), a difference of 8.0%.
That makes Oman's figure about 1.1 times Americas (WHO region)'s.
The two have swapped places 1 time across 5 shared years of data; in 2008 it was Americas (WHO region) ahead.
Americas (WHO region) ranks 2nd and Oman ranks 3rd of 10 groups.
Across the 2 decades both report, Americas (WHO region) averaged higher in 1 and Oman in 1.
Head to head by decade
| Decade | Americas (WHO region) | Oman | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 101.0% | 75.0% | 26.0% | Americas (WHO region) |
| 2010s | 88.0% | 100.0% | 12.0% | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Americas (WHO region) or Oman?
- Oman, at 100.0% against 92.0% in Americas (WHO region) as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Americas (WHO region) and Oman?
- 8.0%, with Oman ahead.
- How many years of comparable data are there for Americas (WHO region) and Oman?
- 5 years are reported by both, from 2008 to 2012.
- How do Americas (WHO region) and Oman rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Americas (WHO region) ranks 2nd and Oman ranks 3rd of 10 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.